This company listing is no longer active
OVN Stock Overview
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Oventus Medical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.15 |
| 52 Week Low | AU$0.017 |
| Beta | 0.89 |
| 1 Month Change | 0% |
| 3 Month Change | -9.09% |
| 1 Year Change | -80.00% |
| 3 Year Change | -96.49% |
| 5 Year Change | -94.03% |
| Change since IPO | -97.14% |
Recent News & Updates
Recent updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now
Nov 11
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?
May 09Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?
Jan 24
Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term
Nov 30Shareholder Returns
| OVN | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | 0.1% |
| 1Y | -80.0% | 6.3% | 9.8% |
Return vs Industry: OVN underperformed the Australian Medical Equipment industry which returned -21.1% over the past year.
Return vs Market: OVN underperformed the Australian Market which returned -9.8% over the past year.
Price Volatility
| OVN volatility | |
|---|---|
| OVN Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.0% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in AU Market | 16.6% |
| 10% least volatile stocks in AU Market | 2.9% |
Stable Share Price: OVN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OVN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | John Cox | o2vent.com |
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.
Oventus Medical Limited Fundamentals Summary
| OVN fundamental statistics | |
|---|---|
| Market cap | AU$4.83m |
| Earnings (TTM) | -AU$10.29m |
| Revenue (TTM) | AU$1.09m |
4.4x
P/S Ratio-0.5x
P/E RatioIs OVN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OVN income statement (TTM) | |
|---|---|
| Revenue | AU$1.09m |
| Cost of Revenue | AU$654.09k |
| Gross Profit | AU$439.45k |
| Other Expenses | AU$10.73m |
| Earnings | -AU$10.29m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.043 |
| Gross Margin | 40.18% |
| Net Profit Margin | -941.33% |
| Debt/Equity Ratio | 0% |
How did OVN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/09/04 16:38 |
| End of Day Share Price | 2022/06/07 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oventus Medical Limited is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Martyn Jacobs | Canaccord Genuity |